Sumitomo Pharma Co., Ltd. is a global pharmaceutical company headquartered in Japan with key operations in the U.S., Canada, and Europe. The company focuses on addressing patient needs across multiple therapeutic areas including oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products already available in the U.S., Canada, and Europe, Sumitomo Pharma maintains a diverse pipeline of early- to late-stage assets aimed at accelerating the discovery, research, and development of novel therapies to bring treatments to patients more quickly.
Beta · Sourced from candidate reports
Be the first to share your experience with Sumitomo Pharma America (SMPA).
Your reply helps other candidates know what to expect.
